Revenue trends

On November 27, GW Pharmaceuticals (GWPH) presented its fourth-quarter and fiscal 2018 financial results. GW Pharmaceuticals’ net revenues in fiscal 2018 were $12.74, which represents ~15.75% YoY (year-over-year) growth. To learn more, read Here Are Some of GW Pharmaceuticals’ Key Growth Drivers.

INSYS Therapeutics (INSY) reported revenues of $18.35 million in the third quarter, which represents an ~40.18% YoY decline. Cara Therapeutics (CARA) reported revenues of $5.03 million. Cara Therapeutics didn’t report revenues in the third quarter of 2017. To learn more, read Cara Therapeutics: A Financial Overview in January.

Cannabis Stocks: CARA, INSY, and GWPH’s Revenue Trajectory

Analysts’ estimates

In the fourth quarter, INSYS Therapeutics and Cara Therapeutics are expected to generate revenues of $18.16 million and $2.67 million, respectively.

Analysts expect that INSYS Therapeutics and Cara Therapeutics’ net revenues in fiscal 2018 will be ~$83.95 million and $10.60 million, respectively, compared to reported revenues of $140.69 million and $0.91 million in fiscal 2017.

In 2019 and 2020, analysts expect Cara Therapeutics to generate net revenues of $11.21 million and $19.11 million, respectively, which represents ~5.73% and ~70.49% YoY growth.

Analysts expect INSYS Therapeutics’ net revenues in 2019 and 2020 to be ~$75.39 million and $102.28 million, which represents an ~10.20% YoY decline and ~35.67% YoY growth.

Cara Therapeutics, INSYS Therapeutics, and GW Pharmaceuticals revenue growth could boost the ETFMG Alternative Harvest ETF’s (MJ) share prices. Cara Therapeutics, INSYS Therapeutics, and GW Pharmaceuticals account for ~1.52%, ~1.64%, and 5.95% of MJ’s total portfolio holding.

Latest articles

President Trump tweeted about his plans to meet with Apple (AAPL) CEO Tim Cook. It's possible that they could discuss Apple’s US manufacturing plans.

WeWork is gearing up for an IPO. On Wednesday, the company made its IPO filing with the SEC public and expects to garner $3.5 billion from its IPO.

After FCC Chairman Ajit Pai recommended the approval of the T-Mobile–Sprint merger, Representative David Cicilline urged the FCC to allow public comment.

Cresco Labs (CRLBF) is set to report its Q2 earnings on August 21 after the market closes. The company's stock fell 5.3% yesterday.

Cannabis stocks mostly traded in positive territory today. Supreme Cannabis (FIRE) and Aurora Cannabis (ACB) rose about 9.5% and 5.5%, respectively.

NVIDIA (NVDA) stock soared 6% in today’s trading session as its Q2 earnings for fiscal 2020 beat estimates. However, its guidance missed estimates.